DMT single dose reduced depression symptoms within a week in trial
A phase IIa randomized trial reported that a single intravenous dose of dimethyltryptamine (DMT) produced significant reductions in depressive symptoms within one to two weeks in adults with moderate to severe depression, with benefits persisting for months in some participants.
